High-sensitive cardiac Troponin T is superior to echocardiography in predicting 1-year mortality in patients with SIRS and shock in intensive care

BMC Anesthesiology

Lill Bergenzaun²  Hans Öhlin¹  Petri Gudmundsson⁴  Joachim Düring²  Ronnie Willenheimer³  Michelle S Chew² 

[1] Department of Cardiology, Institution of Clinical Sciences, Skåne University Hospital, Lund University, Getingevägen 4, S- 22185 , Lund, Sweden

[2] Department of Anaesthesiology and Intensive Care, Institution of Clinical Sciences, Skåne University Hospital, Lund University, Inga Marie Nilssons gata 47, S-20502 , Malmö, Sweden

[3] Heart Health Group, Lund University, Geijersg. 4C, 21618 , Limhamn, Sweden

[4] Department of Biomedical Science, Malmö University, Södra Förstadsgatan 101, S- 20506 , Malmö, Sweden

关键词: Shock;    Mortality;    Myocardial function;    High-sensitive TNT;    BNP;    Echocardiography;   

Others  :  816982
DOI  :  10.1186/1471-2253-12-25

 received in 2012-02-28, accepted in 2012-09-17,  发布年份 2012

【 摘 要 】

Background

Left ventricular (LV) dysfunction is well documented in the critically ill. We assessed 1-year mortality in relation to cardiac biomarkers and LV function parameters by echocardiography in patients with shock.

Methods

A prospective, observational, cohort study of 49 patients. B-natriuretic peptide (BNP), high-sensitive troponin T (hsTNT) and transthoracic echocardiography (TTE) were assessed within 12 h of study inclusion. LV systolic function was measured by ejection fraction (LVEF), mean atrioventricular plane displacement (AVPDm), peak systolic tissue Doppler velocity imaging (TDIs) and velocity time integral in the LV outflow tract (LVOT VTI). LV diastolic function was evaluated by transmitral pulsed Doppler (E, A, E/A, E-deceleration time), tissue Doppler indices (é, á, E/é) and left atrial volume (La volume). APACHE II (Acute Physiology and Chronic Health Evaluation) and SOFA (Sequential Organ Failure Assessment) scores were calculated.

Results

hsTNT was significantly higher in non-survivors than in survivors (60 [17.0-99.5] vs 168 [89.8-358] ng/l, p = 0.003). Other univariate predictors of mortality were APACHE II (p = 0.009), E/é (p = 0.023), SOFA (p = 0.024) and age (p = 0.031). Survivors and non-survivors did not differ regarding BNP (p = 0.26) or any LV systolic function parameter (LVEF p = 0.87, AVPDm p = 0.087, TDIs p = 0.93, LVOT VTI p = 0.18). Multivariable logistic regression analysis identified hsTNT (p = 0.010) as the only independent predictor of 1-year mortality; adjusted odds ratio 2.0 (95% CI 1.2- 3.5).

Conclusions

hsTNT was the only independent predictor of 1-year mortality in patients with shock. Neither BNP nor echocardiographic parameters had an independent prognostic value. Further studies are needed to establish the clinical significance of elevated hsTNT in patients in shock.

【 授权许可】

   
2012 Bergenzaun et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984, 100(4):483-490.
• [2]Ellrodt AG, Riedinger MS, Kimchi A, Berman DS, Maddahi J, Swan HJC, Murata GH: Left ventricular performance in septic shock: reversible segmental and global abnormalities. Am Heart J 1985, 110(2):402-409.
• [3]Ikonomidis I, Nikolaou M, Dimopoulou I, Paraskevaidis I, Lekakis J, Mavrou I, Tzanela M, Kopterides P, Tsangaris I, Armaganidis A, et al.: Association of left ventricular diastolic dysfunction with elevated NT-pro-BNP in general intensive care unit patients with preserved ejection fraction: a complementary role of tissue Doppler imaging parameters and NT-pro-BNP levels for adverse outcome. Shock 2010, 33(2):141-148.
• [4]McLean AS, Huang SJ, Hyams S, Poh G, Nalos M, Pandit R, Balik M, Tang B, Seppelt I: Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007, 35(4):1019-1026.
• [5]Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P, Lindahl B, Giannitsis E, Hasin Y, Galvani M, et al.: Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010, 31(18):2197-2204.
• [6]Poelaert J, Declerck C, Vogelaers D, Colardyn F, Visser CA: Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 1997, 23(5):553-560.
• [7]Munt B, Jue J, Gin K, Fenwick J, Tweeddale M: Diastolic filling in human severe sepsis: an echocardiographic study. Crit Care Med 1998, 26(11):1829-1833.
• [8]Bouhemad B, Nicolas-Robin A, Arbelot C, Arthaud M, Feger F, Rouby JJ: Acute left ventricular dilatation and shock-induced myocardial dysfunction. Crit Care Med 2009, 37(2):441-447.
• [9]Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, et al.: Universal definition of myocardial infarction. Circulation 2007, 116(22):2634-2653.
• [10]Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA: Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010, 56(2):254-261.
• [11]Weber M, Bazzino O, Navarro Estrada JL, de Miguel R, Salzberg S, Fuselli JJ, Liebetrau C, Woelken M, Moellmann H, Nef H, et al.: Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. Am Heart J 2011, 162(1):81-88.
• [12]Bonaca M, Scirica B, Sabatine M, Dalby A, Spinar J, Murphy SA, Jarolim P, Braunwald E, Morrow DA: Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. J Am Coll Cardiol 2010, 55(19):2118-2124.
• [13]de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD, Das SR, Morrow DA, et al.: Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010, 304(22):2503-2512.
• [14]Lim W, Qushmaq I, Devereaux PJ, Heels-Ansdell D, Lauzier F, Ismaila AS, Crowther MA, Cook DJ: Elevated cardiac troponin measurements in critically ill patients. Arch Intern Med 2006, 166(22):2446-2454.
• [15]Reynolds T, Cecconi M, Collinson P, Rhodes A, Grounds RM, Hamilton MA: Raised serum cardiac troponin I concentrations predict hospital mortality in intensive care unit patients. Br J Anaesth 2012, 109(2):219-224.
• [16]Ammann P, Maggiorini M, Bertel O, Haenseler E, Joller-Jemelka HI, Oechslin E, Minder EI, Rickli H, Fehr T: Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003, 41(11):2004-2009.
• [17]Rosjo H, Varpula M, Hagve TA, Karlsson S, Ruokonen E, Pettila V, Omland T: Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med 2011, 37(1):77-85.
• [18]de Lemos JA, McGuire DK, Drazner MH: B-type natriuretic peptide in cardiovascular disease. Lancet 2003, 362(9380):316-322.
• [19]Alehagen U, Lindstedt G, Levin LA, Dahlstrom U: Risk of cardiovascular death in elderly patients with possible heart failure. B-type natriuretic peptide (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up of a primary care population. Int J Cardiol 2005, 100(1):125-133.
• [20]Omland T: Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure. Crit Care Med 2008, 36(1 Suppl):S17-S27.
• [21]Almog Y, Novack V, Megralishvili R, Kobal S, Barski L, King D, Zahger D: Plasma level of N terminal pro-brain natriuretic peptide as a prognostic marker in critically ill patients. Anesth Analg 2006, 102(6):1809-1815.
• [22]Tung RH, Garcia C, Morss AM, Pino RM, Fifer MA, Thompson BT, Lewandrowski K, Lee-Lewandrowski E, Januzzi JL: Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 2004, 32(8):1643-1647.
• [23]Cholley BP, Vieillard-Baron A, Mebazaa A: Echocardiography in the ICU: time for widespread use! Intensive Care Med 2006, 32(1):9-10.
• [24]Sturgess DJ, Marwick TH, Joyce CJ, Jones M, Venkatesh B: Tissue Doppler in critical illness: a retrospective cohort study. Crit Care 2007, 11(5):R97. BioMed Central Full Text
• [25]Sturgess DJ, Marwick TH, Joyce C, Jenkins C, Jones M, Masci P, Stewart D, Venkatesh B: Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers. Crit Care 2010, 14(2):R44. BioMed Central Full Text
• [26]Willenheimer R, Cline C, Erhardt L, Israelsson B: Left ventricular atrioventricular plane displacement: an echocardiographic technique for rapid assessment of prognosis in heart failure. Heart 1997, 78(3):230-236.
• [27]Jensen-Urstad K, Bouvier F, Hojer J, Ruiz H, Hulting J, Samad B, Thorstrand C, Jensen-Urstad M: Comparison of different Echocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy. Am J Cardiol 1998, 81(5):538-544.
• [28]Nikitin NP, Witte KKA: Application of tissue Doppler imaging in cardiology. Cardiology 2004, 101(4):170-184.
• [29]Thomas DE, Yousef ZR, Fraser AG: A critical comparison of echocardiographic measurements used for optimizing cardiac resynchronization therapy: stroke distance is best. Eur J Heart Fail 2009, 11(8):779-788.
• [30]Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A: Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009, 22(2):107-133.
• [31]Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, et al.: Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32(3):858-873.
• [32]Chew MS, Ihrman L, During J, Bergenzaun L, Ersson A, Unden J, Ryden J, Akerman E, Larsson M: Extravascular lung water index improves the diagnostic accuracy of lung injury in patients with shock. Crit Care 2012, 16(1):R1. BioMed Central Full Text
• [33]Knaus WA, Draper EA, Wagner DP, Zimmerman JE: Prognosis in acute organ-system failure. Ann Surg 1985, 202(6):685-693.
• [34]Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 1998, 26(11):1793-1800.
• [35]Bergenzaun L, Gudmundsson P, Ohlin H, During J, Ersson A, Ihrman L, Willenheimer R, Chew M: Assessing left ventricular systolic function in shock: evaluation of echocardiographic parameters in intensive care. Crit Care 2011, 15(4):R200. BioMed Central Full Text
• [36]Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH, Lee MM, Park YB, Choi YS, Seo JD, et al.: Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997, 30(2):474-480.
• [37]Lester SJ, Ryan EW, Schiller NB, Foster E: Best method in clinical practice and in research studies to determine left atrial size. Am J Cardiol 1999, 84(7):829-832.
• [38]Bewick V, Cheek L, Ball J: Statistics review 14: logistic regression. Crit Care 2005, 9(1):112-118. BioMed Central Full Text
• [39]Greenland S: Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989, 79(3):340-349.
• [40]Strand K, Flaatten H: Severity scoring in the ICU: a review. Acta Anaesthesiol Scand 2008, 52(4):467-478.
• [41]Lim W, Whitlock R, Khera V, Devereaux PJ, Tkaczyk A, Heels-Ansdell D, Jacka M, Cook D: Etiology of troponin elevation in critically ill patients. J Crit Care 2010, 25(2):322-328.
• [42]Babuin L, Vasile VC, Rio Perez JA, Alegria JR, Chai HS, Afessa B, Jaffe AS: Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Crit Care Med 2008, 36(3):759-765.
• [43]Mehta NJ, Khan IA, Gupta V, Jani K, Gowda RM, Smith PR: Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol 2004, 95(1):13-17.
• [44]Wu TT, Yuan A, Chen CY, Chen WJ, Luh KT, Kuo SH, Lin FY, Yang PC: Cardiac troponin I levels are a risk factor for mortality and multiple organ failure in noncardiac critically ill patients and have an additive effect to the APACHE II score in outcome prediction. Shock 2004, 22(2):95-101.
• [45]Twerenbold R, Jaffe A, Reichlin T, Reiter M, Mueller C: High-sensitive troponin T measurements: what do we gain and what are the challenges? Eur Heart J 2012, 33(5):579-586.
• [46]McGill D, Talaulikar G, Potter JM, Koerbin G, Hickman PE: Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure. Clin Chim Acta 2010, 411(13–14):936-939.
• [47]Jardin F, Fourme T, Page B, Loubieres Y, Vieillard-Baron A, Beauchet A, Bourdarias JP: Persistent preload defect in severe sepsis despite fluid loading: A longitudinal echocardiographic study in patients with septic shock. Chest 1999, 116(5):1354-1359.